Tag: XBIO Technology

All

TELA Bio Launches SiteGuard No Rinse Antimicrobial Solution for Plastic Reconstructive Surgery

Malvern, Pa.-based TELA Bio, Inc. has commercially launched the SiteGuard No Rinse Antimicrobial Solution for use in plastic reconstructive surgery.

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors
Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction
Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Tag: XBIO Technology

All

TELA Bio Launches SiteGuard No Rinse Antimicrobial Solution for Plastic Reconstructive Surgery

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links